why choose us

First received: May 18, 2023

Clinical Trial: Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Acne Vulgaris

Study Type: INTERVENTIONAL


Official Title: Topical Androgen Receptor Inhibitor for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

Brief Summary: Mechanism-based acne treatment for transgender patients receiving testosterone currently does not exist and is an unmet medical need.This study explores clascoterone to treat testosterone induced acne.Many treatments we use to treat acne in females cannot be used in transgender males because they interfere with hormone therapy.Androgens have been associated with the development of acne vulgaris.Recently, a topical androgen receptor inhibitor cream (clascoterone) has been FDA-approved for the treatment of…

Read more